United Kingdom· GB-APID-36897711000001102
Stivarga 40mg tablets
A regorafenib product containing regorafenib, registered in United Kingdom by Originalis B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Regorafenib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EX05 (regorafenib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Regorafenib · ATC L01EX05
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of regorafenib costs, country by country.
Normalised to the WHO defined daily dose (0.12 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Regorafenib · price per daily dose (0.12 g)
USD · FX 28 Sept 2026
- IT Italy$140.25
- CH Switzerland$139.52
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Regorafenib
- Manufacturer
- Originalis B.V.
- Country
- United Kingdom (GB)
- ATC code
- L01EX05
- ATC class
- Regorafenib
- Defined daily dose
- 0.12 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin08719923003983
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
248 interactions on record for regorafenib.
Graded by severity as the source publishes them — 116 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Regorafenib · interactions on record
248 records
- 116 severe
- 125 moderate
- 7 minor
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Regorafenib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaSTIVARGABAYER INC
- FinlandStivargaParanova Oy
- CzechiaSTIVARGABayer AG, Leverkusen
- SwitzerlandStivarga 40 mg, FilmtablettenBayer (Schweiz) AG
- SpainSTIVARGA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
- FranceSTIVARGA 40 mg, comprimé pelliculéBAYER AG (ALLEMAGNE)
- IrelandStivarga 40 mg film-coated tabletsBayer Pharma AG
- IcelandStivargaBayer AG*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Stivarga
- Liechtenstein · Stivarga
- Norway · Stivarga
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0e13fd57-a189-4195-929a-a9eab529d316 GET /v1/drugs/0e13fd57-a189-4195-929a-a9eab529d316?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "36897711000001102",
"desc": "Stivarga 40mg tablets (Originalis B.V.)",
"form": "Oral tablet",
"vpid": "41768511000001108",
"source": "dmd",
"vtm_id": "777416007",
"strength": "40 mg",
"substance": "Regorafenib",
"ingredient": "Regorafenib",
"supplier_code": "36751511000001108"
}See everything about regorafenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.